Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

For example, about 44% of individuals in each treatment arm experienced nausea and 25% ... compared with 16% of those who received semaglutide. The improved performance is likely linked to ...

Weight loss injections could be available in Northern Ireland on the health service, after the first regional obesity ...

Detailed price information for Vivani Medical Inc (VANI-Q) from The Globe and Mail including charting and trades.

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

When multibillion-pound global corporations invest huge sums in medical companies to develop new treatments for serious ...

Ozempic, a prescription drug typically used to manage type 2 diabetes, is fast turning into an answer for quick weight loss ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...